Attenuated bioluminescent Brucella melitensis mutants GR019 (virB4), GR024 (galE), and GR026 (BMEI1090-BMEI1091) confer protection in mice

Infection and Immunity

Volumn 74, Issue 5, 2006, Pages 2925-2936

  Rajashekara, Gireesh ^a   Glover, David A ^a   Banai, Menachem ^b   O'Callaghan, David ^c   Splitter, Gary A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b KIMRON VETERINARY INSTITUTE   (Israel)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; INTERFERON REGULATORY FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BIOLUMINESCENCE; BRUCELLA MELITENSIS; CELL CULTURE; CONTROLLED STUDY; GALE GENE; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TISSUE DISTRIBUTION; VIRB4 GENE;

ANIMALS; BRUCELLA MELITENSIS; BRUCELLA VACCINE; CELL LINE; INTERFERON REGULATORY FACTOR-1; LIPOPOLYSACCHARIDES; LUMINESCENT MEASUREMENTS; MICE; MICE, INBRED C57BL; MUTATION; VACCINATION;

EID: 33646366903     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.5.2925-2936.2006     Document Type: Article

References (46)

1. Adhya, S. 1987. The galactose operon, p. 1503-1512. In F. C. Neidhardt, K. B. Low, B. Magasanik, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella typhimurium: cellular and molecular biology. American Society for Microbiology, Washington, D.C.
2. Alton, G. G., S. S. Elberg, and D. Crouch. 1967. Rev. 1 Brucella melitensis vaccine. The stability of the degree of attenuation. J. Comp. Pathol. 77:293-300.
3. Arellano-Reynoso, B., N. Lapaque, S. Salcedo, G. Briones, A. E. Ciocchini, R. Ugalde, E. Moreno, I. Moriyon, and J. P. Gorvel. 2005. Cyclic beta-1,2-glucan is a Brucella virulence factor required for intracellular survival. Nat. Immunol. 6:618-625.
4. Bardenstein, S., M. Mandelboim, T. A. Ficht, M. Baum, and M. Banai. 2002. Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene. J. Clin. Microbiol. 40:1475-1480.
5. Blasco, J. M. 1997. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats. Prev. Vet. Med. 31:275-283.
6. Boschiroli, M. L., V. Foulongne, and D. O'Callaghan. 2001. Brucellosis: a worldwide zoonosis. Curr. Opin. Microbiol. 4:58-64.
7. Braun, W., and A. E. Bonestell. 1947. Independent variation of characteristics in Brucella abortus variants and their detection. Am. J. Vet. Res. 8:386-390.
8. Celli, J., C. de Chastellier, D. M. Franchini, J. Pizarro-Cerda, E. Moreno, and J. P. Gorvel. 2003. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J. Exp. Med. 198:545-556.
9. Celli, J., and J. P. Gorvel. 2004. Organelle robbery: Brucella interactions with the endoplasmic reticulum. Curr. Opin. Microbiol. 7:93-97.
10. Comerci, D. J., M. J. Martinez-Lorenzo, R. Sieira, J. P. Gorvel, and R. A. Ugalde. 2001. Essential role of the VirB machinery in the maturation of the Brucella abortus-containing vacuole. Cell. Microbiol. 3:159-168.
11. Contag, C. H., P. R. Contag, J. I. Mullins, S. D. Spilman, D. K. Stevenson, and D. A. Benaron. 1995. Photonic detection of bacterial pathogens in living hosts. Mol. Microbiol. 18:593-603.
12. Corbel, M. J. 1997. Brucellosis: an overview. Emerg. Infect. Dis. 3:213-221.
13. DelVecchio, V. G., V. Kapatral, R. J. Redkar, G. Patra, C. Mujer, T. Los, N. Ivanova, I. Anderson, A. Bhattacharyya, A. Lykidis, G. Reznik, L. Jablonski, N. Larsen, M. D'Souza, A. Bernal, M. Mazur, E. Goltsman, E. Selkov, P. H. Elzer, S. Hagius, D. O'Callaghan, J. J. Letesson, R. Haselkorn, N. Kyrpides, and R. Overbeek. 2002. The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proc. Natl. Acad. Sci. USA 99:443-448.
14. Elberg, S. S., and K. Faunce, Jr. 1957. Immunization against Brucella infection. VI. Immunity conferred on goats by a nondependent mutant from a streptomycin-dependent mutant strain of Brucella melitensis. J. Bacteriol. 73:211-217.
15. Foulongne, V., G. Bourg, C. Cazevieille, S. Michaux-Charachon, and D. O'Callaghan. 2000. Identification of Brucella suis genes affecting intracellular survival in an in vitro human macrophage infection model by signature-tagged transposon mutagenesis. Infect. Immun. 68:1297-1303.
16. Fry, B. N., S. Feng, Y. Y. Chen, D. G. Newell, P. J. Coloe, and V. Korolik. 2000. The galE gene of Campylobacter jejuni is involved in lipopolysaccharide synthesis and virulence. Infect. Immun. 68:2594-2601.
17. Hardy, J., K. P. Francis, M. DeBoer, P. Chu, K. Gibbs, and C. H. Contag. 2004. Extracellular replication of Listeria monocytogenes in the murine gall bladder. Science 303:851-853.
18. Hong, P. C., R. M. Tsolis, and T. A. Ficht. 2000. Identification of genes required for chronic persistence of Brucella abortus in mice. Infect. Immun. 68:4102-4107.
19. Houng, H. S., D. J. Kopecko, and L. S. Baron. 1990. Molecular cloning and physical and functional characterization of the Salmonella typhimurium and Salmonella typhi galactose utilization operons. J. Bacteriol. 172:4392-4398.
20. Jimenez de Bagues, M. P., A. Gross, A. Terraza, and J. Dornand. 2005. Regulation of the mitogen-activated protein kinases by Brucella spp. expressing a smooth and rough phenotype: relationship to pathogen invasiveness. Infect. Immun. 73:3178-3183.
21. Ko, J., A. Gendron-Fitzpatrick, T. A. Ficht, and G. A. Splitter. 2002. Virulence criteria for Brucella abortus strains as determined by interferon regulatory factor 1-deficient mice. Infect. Immun. 70:7004-7012.
22. Ko, J., and G. A. Splitter. 2003. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin. Microbiol. Rev. 16:65-78.
23. Kohler, S., V. Foulongne, S. Ouahrani-Bettache, G. Bourg, J. Teyssier, M. Ramuz, and J. P. Liautard. 2002. The analysis of the intramacrophagic virulome of Brucella suis deciphers the environment encountered by the pathogen inside the macrophage host cell. Proc. Natl. Acad. Sci. USA 99:15711-15716.
24. Kovach, M. E., P. H. Elzer, D. S. Hill, G. T. Robertson, M. A. Farris, R. M. Roop II, and K. M. Peterson. 1995. Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene 166:175-176.
25. Lapaque, N., I. Moriyon, E. Moreno, and J. P. Gorvel. 2005. Brucella lipopolysaccharide acts as a virulence factor. Curr. Opin. Microbiol. 8:60-66.
26. Lestrate, P., R. M. Delrue, I. Danese, C. Didembourg, B. Taminiau, P. Mertens, X. De Bolle, A. Tibor, C. M. Tang, and J. J. Letesson. 2000. Identification and characterization of in vivo attenuated mutants of Brucella melitensis. Mol. Microbiol. 38:543-551.
27. Madkour, M. M. 2001. Osteoarticular brucellosis, p. 74-84. In M. M. Makour (ed.), Madkour's brucellosis. Springer, Heidelberg, Germany.
28. Martinez de Tejada, G., J. Pizarro-Cerda, E. Moreno, and I. Moriyon. 1995. The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides. Infect. Immun. 63:3054-3061.
29. Metzger, M., P. Bellemann, P. Bugert, and K. Geider. 1994. Genetics of galactose metabolism of Erwinia amylovora and its influence on polysaccharide synthesis and virulence of the fire blight pathogen. J. Bacteriol. 176:450-459.
30. Monreal, D., M. J. Grillo, D. Gonzalez, C. M. Marin, M. J. De Miguel, I. Lopez-Goni, J. M. Blasco, A. Cloeckert, and I. Moriyon. 2003. Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model. Infect. Immun. 71:3261-3271.
31. Moriyón, I., M. J. Grilló, D. Monreal, D. González, C. Marín, I. López-Gon̄i, R. C. Mainar-Jaime, E. Moreno, and J. M. Blasco. 2004. Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet. Res. 35:1-38.
32. 1 in entry and short-term survival of Brucella suis in murine macrophages. Infect. Immun. 70:1640-1644.
33. O'Callaghan, D., C. Cazevieille, A. Allardet-Servent, M. L. Boschiroli, G. Bourg, V. Foulongne, P. Frutos, Y. Kulakov, and M. Ramuz. 1999. Homologue of the Agrobacterium tumefaciens VirB and Bordetella pertussis Ptl type IV secretion systems is essential for intracellular survival of Brucella suis. Mol. Microbiol. 33:1210-1220.
34. Pei, J., and T. A. Ficht. 2004. Brucella abortus rough mutants are cytopathic for macrophages in culture. Infect. Immun. 72:440-450.
35. Petrovska, L., R. G. Hewinson, G. Dougan, D. J. Maskell, and M. J. Woodward. 1999. Brucella melitensis 16M: characterisation of the galE gene and mouse immunisation studies with a galE deficient mutant. Vet. Microbiol. 65:21-36.
36. Pierson, D. E., and S. Carlson. 1996. Identification of the galE gene and a galE homolog and characterization of their roles in the biosynthesis of lipopolysaccharide in a serotype O:8. strain of Yersinia enterocolitica. J. Bacteriol. 178:5916-5924.
37. Plommet, M. 1991. Minimal requirements for growth of Brucella suis and other Brucella species. Zentbl. Bakteriol. 275:436-450.
38. Plommet, M. 1995. Live vaccines: virulence, immunogenicity/protection and safety. Historical, theoretical and practical considerations applied to the Brucella melitensis Rev. 1 vaccine, p. 7-18. In B. Garin-Bastugi and A. Benkirane (ed.), FAO/WHO/OIE Round Table on the Use of Rev. 1 Vaccine in Small Ruminants and Cattle, 21 to 22 September 1995. Centre National d'Etudes Vétérinaires et Alimentaires, Maison-Alfort, France.
39. Porte, F., A. Naroeni, S. Ouahrani-Bettache, and J. P. Liautard. 2003. Role of the Brucella suis lipopolysaccharide O antigen in phagosomal genesis and in inhibition of phagosome-lysosome fusion in murine macrophages. Infect. Immun. 71:1481-1490.
40. Rajashekara, G., D. A. Glover, M. Krepps, and G. A. Splitter. 2005. Temporal analysis of pathogenic events in virulent and avirulent Brucella melitensis infections. Cell. Microbiol. 10:1459-1473.
41. Rittig, M. G., A. Kaufmann, A. Robins, B. Shaw, H. Sprenger, D. Gemsa, V. Foulongne, B. Rouot, and J. Dornand. 2003. Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes. J. Leukoc. Biol. 74:1045-1055.
42. Schurig, G. G., N. Sriranganathan, and M. J. Corbel. 2002. Brucellosis vaccines: past, present and future. Vet. Microbiol. 90:479-496.
43. Scupham, A. J., and E. W. Triplett. 1997. Isolation and characterization of the UDP-glucose 4′-epimerase-encoding gene, galE, from Brucella abortus 2308. Gene 202:53-59.
44. Taniguchi, T., K. Ogasawara, A. Takaoka, and N. Tanaka. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623-655.
45. Unsworth, K. E., and D. W. Holden. 2000. Identification and analysis of bacterial virulence genes in vivo. Philos. Trans. R. Soc. Lond. B 355:613-622.
46. Young, E. J. 1995. An overview of human brucellosis. Clin. Infect. Dis. 21:283-289.